Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of the protein-peptide complex isolated from the thyroid gland tissue of young gobies
Physiological effect: Viorgon-12 is associated with its property to additionally activate cellular sources of regeneration in the gland, maintain the viability of glandular cells, as well as intercellular adhesive interactions.
Indications for use: viorgon-12 is recommended for diseases of the thyroid gland (together with viorgons 1, 3, 29, 30), as well as organs of the reproductive system, ovaries, mammary gland, menstrual irregularities. Viorgon-12 is combined with the intake of other viorgons (especially Viorgon-1, Viorgon-3, Viorgon-29 and Viorgon-30), as well as medicines.
Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.
Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.
A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.
The interval between the various viorgons is at least 10 minutes.